Pyrimidine, quinazoline, pteridine and triazine derivatives
申请人:Binggeli Alfred
公开号:US20070225271A1
公开(公告)日:2007-09-27
This invention is concerned with compounds of the formula
wherein A, R
1
to R
5
and G are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are associated with the modulation of SST receptors subtype 5.
This invention is concerned with compounds of the formula
wherein A, R
1
to R
5
are as defined in the specification and G is a pyridine, quinoline or pyrimidine group as defined in the specification, and pharmaceutically acceptable salts thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are associated with the modulation of SST receptors subtype 5.
Phenyl, Pyridine, Quinoline, Isoquinoline, Naphthyridine and Pyrazine Derivatives
申请人:Binggeli Alfred
公开号:US20080045544A1
公开(公告)日:2008-02-21
This invention is concerned with compounds of the formula
and pharmaceutically acceptable salts thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are associated with the modulation of SST receptors subtype 5.
Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives
申请人:Binggeli Alfred
公开号:US20060205718A1
公开(公告)日:2006-09-14
This invention is concerned with compounds of the formula
wherein A, B
1
, B
2
, R
1
, R
2
and G are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are associated with the modulation of SST receptors subtype 5.
The invention relates to polymeric transition metal catalysts, to processes for preparing them, to intermediates and also to the use of the transition metal catalysts as catalysts in organic reactions, in particular in olefin metathesis reactions.